ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,07101
0,01%
Bitcoin
61.779,31
-0,05%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

  7. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DatumZeitQuelleÜberschriftSymbolFirma
13/01/201118h00PR Newswire (US)ANGIOTECH PHARMACEUTICALS ANNOUNCES DELISTING FROM THE NASDAQ STOCK MARKET AND TRANSFER TO OTCQB™ MARKETPLACENASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
12/01/201121h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support AgreemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/01/201123h26Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/01/201122h48Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/01/201102h00PR Newswire (US)ANGIOTECH PHARMACEUTICALS ANNOUNCES NOTICE OF DELISTING FROM THE NASDAQ STOCK MARKETNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/12/201017h49Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/12/201020h30PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Agreement to Extend Cure Period Under Subordinated Note IndentureNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/12/201022h48Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/12/201018h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support AgreemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
02/12/201023h20Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
02/12/201018h18PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Preliminary Injunction Ruling In Connection With Rex Medical L.P. LitigationNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
02/12/201018h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support AgreemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
29/11/201018h30PR Newswire (US)ANGIOTECH PHARMACEUTICALS ANNOUNCES PRIVATE LABEL PRODUCT SUPPLY AGREEMENT WITH HOLOGICNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/11/201020h15PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LPNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
16/11/201023h08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/11/201022h35Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/11/201020h42Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/11/201011h00PR Newswire (US)ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2010NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
02/11/201011h04Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
30/10/201002h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial InformationNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
30/10/201002h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported Transaction Agreement with Majority of Senior Subordinated NotehoNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/10/201001h00PR Newswire (US)ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCASTNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/10/201020h57Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/10/201014h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against tNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
01/10/201014h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes. Angiotech Conducting Discussions With NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/09/201017h30PR Newswire (US)ANGIOTECH ANNOUNCES THAT COOK MEDICAL'S ZILVER(R) PTX(R) DRUG-ELUTING STENT MEETS ITS PRIMARY ENDPOINT IN A 479-PATIENT, MULTI-CNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/09/201020h30PR Newswire (US)ANGIOTECH PHARMACEUTICALS AND PARTNER ATHERSYS ANNOUNCE UPDATED RESULTS FROM PHASE I STUDY OF MULTISTEM(R) IN HEART ATTACK PATIENASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/09/201020h45PR Newswire (US)ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION'S PLATINUM CHROMIUM TAXUS(R)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/09/201020h45PR Newswire (US)ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGES FOR TAXUS(R) LIBERTÉ(R) STENT IN SMALL VESSELS AND LONG LESIONSNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/08/201022h40Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Kürzlich von Ihnen besucht

TG
TUI1
Tui
TG
CBK
Commerzbank
USOTC
BASFY
BASF (QX)
TG
D7G
Nel ASA
NYSE
JPM
JP Morgan Chase
PM
XAUUSD
Gold vs US Dollar
DBI
DAX
DAX
TG
432
Arbor Metals
FX
EURGBP
Euro vs Sterling
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
NYSE
MCD
McDonalds
TG
MBG
MercedesBenz
TG
DTE
Deutsche Telekom
DBI
MDAX
MDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten